Plasma Biomarker Effects of Oral Valiltramiprosate/ALZ-801 in Early Alzheimer's Disease from Phase 3 and Phase 2 Trials: Analysis of Core Biomarkers and Correlations with Clinical and Neuroimaging Outcomes.

Conceptio › Archive › NCBI PubMed Central

NCBI PubMed Centralopen access

Hey JA et al. · 2026

NCBI PubMed Central · Papers · License: Open Access · 2026

cognitive psychology

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1107410
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.